Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Stabilization of 14-3-3 protein-protein interactions with Fusicoccin-A decreases alpha-synuclein dependent cell-autonomous death in neuronal and mouse models.
Vinueza-Gavilanes R, Bravo-González JJ, Basurco L, Boncristiani C, Fernández-Irigoyen J, Santamaría E, Marcilla I, Pérez-Mediavilla A, Luquin MR, Vales A, González-Aseguinolaza G, Aymerich MS, Aragón T, Arrasate M. Vinueza-Gavilanes R, et al. Among authors: luquin mr. Neurobiol Dis. 2023 Jul;183:106166. doi: 10.1016/j.nbd.2023.106166. Epub 2023 May 26. Neurobiol Dis. 2023. PMID: 37245833 Free article.
Encapsulation of MSCs and GDNF in an Injectable Nanoreinforced Supramolecular Hydrogel for Brain Tissue Engineering.
Torres-Ortega PV, Del Campo-Montoya R, Plano D, Paredes J, Aldazabal J, Luquin MR, Santamaría E, Sanmartín C, Blanco-Prieto MJ, Garbayo E. Torres-Ortega PV, et al. Among authors: luquin mr. Biomacromolecules. 2022 Nov 14;23(11):4629-4644. doi: 10.1021/acs.biomac.2c00853. Epub 2022 Oct 26. Biomacromolecules. 2022. PMID: 36288499 Free PMC article.
Impact of Safinamide on Patient-Reported Outcomes in Parkinson's Disease.
Espinoza-Vinces C, Villino-Rodríguez R, Atorrasagasti-Villar A, Martí-Andrés G, Luquin MR. Espinoza-Vinces C, et al. Among authors: luquin mr. Patient Relat Outcome Meas. 2023 Oct 10;14:285-295. doi: 10.2147/PROM.S369590. eCollection 2023. Patient Relat Outcome Meas. 2023. PMID: 37840836 Free PMC article. Review.
Staging Parkinson's Disease According to the MNCD (Motor/Non-motor/Cognition/Dependency) Classification Correlates with Disease Severity and Quality of Life.
Santos-García D, de Deus Fonticoba T, Cores Bartolomé C, Feal Painceiras MJ, Íñiguez-Alvarado MC, García Díaz I, Jesús S, Buongiorno MT, Planellas L, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Puente V, Dotor García-Soto J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Menéndez González M, Seijo M, Ruiz Martínez J, Valero C, Kurtis M, González Ardura J, Alonso Redondo R, Ordás C, López Díaz LM, McAfee D, Calopa M, Carrillo F, Escamilla Sevilla F, Freire-Alvarez E, Gómez Esteban JC, García Ramos R, Luquín MRI, Martínez-Torres I, Sesar Ignacio Á, Martinez-Martin P, Mir P; COPPADIS Study Group. Santos-García D, et al. Among authors: luquin mri. J Parkinsons Dis. 2023;13(3):379-402. doi: 10.3233/JPD-225073. J Parkinsons Dis. 2023. PMID: 36911948 Free PMC article.
Hydrogels for brain repair: application to Parkinson's disease.
Del Campo-Montoya R, Luquin MR, Puerta E, Garbayo E, Blanco-Prieto MJ. Del Campo-Montoya R, et al. Among authors: luquin mr. Expert Opin Drug Deliv. 2022 Nov;19(11):1521-1537. doi: 10.1080/17425247.2022.2136161. Epub 2022 Nov 1. Expert Opin Drug Deliv. 2022. PMID: 36240170
Trial of Prasinezumab in Early-Stage Parkinson's Disease.
Pagano G, Taylor KI, Anzures-Cabrera J, Marchesi M, Simuni T, Marek K, Postuma RB, Pavese N, Stocchi F, Azulay JP, Mollenhauer B, López-Manzanares L, Russell DS, Boyd JT, Nicholas AP, Luquin MR, Hauser RA, Gasser T, Poewe W, Ricci B, Boulay A, Vogt A, Boess FG, Dukart J, D'Urso G, Finch R, Zanigni S, Monnet A, Pross N, Hahn A, Svoboda H, Britschgi M, Lipsmeier F, Volkova-Volkmar E, Lindemann M, Dziadek S, Holiga Š, Rukina D, Kustermann T, Kerchner GA, Fontoura P, Umbricht D, Doody R, Nikolcheva T, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Among authors: luquin mr. N Engl J Med. 2022 Aug 4;387(5):421-432. doi: 10.1056/NEJMoa2202867. N Engl J Med. 2022. PMID: 35921451 Clinical Trial.
Alpha-synuclein seeding shows a wide heterogeneity in multiple system atrophy.
Martinez-Valbuena I, Visanji NP, Kim A, Lau HHC, So RWL, Alshimemeri S, Gao A, Seidman MA, Luquin MR, Watts JC, Lang AE, Kovacs GG. Martinez-Valbuena I, et al. Among authors: luquin mr. Transl Neurodegener. 2022 Feb 7;11(1):7. doi: 10.1186/s40035-022-00283-4. Transl Neurodegener. 2022. PMID: 35125105 Free PMC article.
MNCD: A New Tool for Classifying Parkinson's Disease in Daily Clinical Practice.
Santos García D, Álvarez Sauco M, Calopa M, Carrillo F, Escamilla Sevilla F, Freire E, García Ramos R, Kulisevsky J, Gómez Esteban JC, Legarda I, Luquín MRI, Castrillo JCM, Martínez-Martin P, Martínez-Torres I, Mir P, Ignacio ÁS. Santos García D, et al. Among authors: luquin mri. Diagnostics (Basel). 2021 Dec 28;12(1):55. doi: 10.3390/diagnostics12010055. Diagnostics (Basel). 2021. PMID: 35054222 Free PMC article.
160 results